Sangamo Therapeutics

Sangamo secures $50M upfront in neurodegenerative pact with Roche's Genentech
Fierce Biotech
Tue, 08/6/24 - 11:34 am
Sangamo Therapeutics
Roche
Genentech
neurodegenerative disease
Rani and Sangamo jettison staff, offices and assets to keep businesses afloat next year
Fierce Biotech
Thu, 11/2/23 - 11:32 am
Rani Therapeutics
Sangamo Therapeutics
RT-102
RT-111
layoffs
Sangamo to lay off 120 as it pares pipeline
BioPharma Dive
Thu, 04/27/23 - 10:41 pm
Sangamo Therapeutics
layoffs
Novartis, Biogen Scrap Gene Regulation Partnerships with Sangamo
BioSpace
Mon, 03/20/23 - 09:51 am
Sangamo Therapeutics
Novartis
Biogen
neurology
gene regulation therapies
Another Pfizer gene therapy is free of FDA hold, but delay continues
Fierce Biotech
Tue, 05/3/22 - 10:53 pm
Pfizer
FDA
clinical trials
hemophilia A
gene therapy
giroctocogene fitelparvovec
Sangamo Therapeutics
Sanofi cuts ties with Sangamo, sharpening focus on 'off-the-shelf' cell therapy
BioPharma Dive
Thu, 01/6/22 - 12:39 pm
Sanofi
Sangamo Therapeutics
cell therapy
sickle cell disease
Sangamo's Fabry gene therapy clears early clinical test, firing starting gun on preparations for phase 3
Fierce Biotech
Thu, 11/4/21 - 10:48 am
Sangamo Therapeutics
Fabry disease
gene therapy
clinical trials
ST-920
Pfizer tears up gene therapy timelines, revealing a series of phase 3 delays that end vision of a banner 2022
Fierce Biotech
Wed, 11/3/21 - 10:43 am
Pfizer
gene therapy
hemophilia
Duchenne Muscular Dystrophy
Sangamo Therapeutics
Gene therapy for Fabry: early stages, promising results
BioPharma Dive
Thu, 07/22/21 - 10:02 pm
gene therapy
Fabry disease
uniQure
Avrbio
Freeline Therapeutics
Sangamo Therapeutics
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment SB-525
Drugs.com
Wed, 10/7/20 - 11:33 pm
Pfizer
Sangamo Therapeutics
genomics
clinical trials
hemophilia A
giroctocogene fitelparvovec
SB-525
Sangamo and Novartis Enter Agreement to Focus on Neurodevelopmental Diseases
BioSpace
Thu, 07/30/20 - 11:23 pm
Novartis
Sangamo Therapeutics
gene regulation therapies
autism
neurodevelopmental disorders
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Thu, 02/27/20 - 11:43 pm
Sangamo Therapeutics
Biogen
gene therapy
gene editing
Parkinson's Disease
Alzheimer's disease
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
Sun, 02/23/20 - 06:17 pm
beta thalassemia
rare disease
drug development
Acceleron
Bristol-Myers Squibb
Bluebird Bio
Sangamo Therapeutics
Vertex Pharmaceuticals
Editas Medicine
Syros Pharmaceuticals
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Mon, 07/1/19 - 10:32 am
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Does Sangamo Have the Best Gene Therapy Program Now?
Motley Fool
Wed, 04/3/19 - 12:28 pm
Sangamo Therapeutics
gene therapy
SB-525
hemophilia A
Should Sangamo's Failure Make CRISPR Investors Nervous?
Motley Fool
Sun, 02/10/19 - 01:52 pm
Sangamo Therapeutics
gene editing
CRISPR
CRISPR Therapeutics
Editas Medicine
Cutting-edge biotech Sangamo stock dives 12% after JPMorgan cites ‘growing skepticism’ in downgrade
Marketwatch
Thu, 11/15/18 - 09:50 am
Sangamo Therapeutics
Sangamo falls on 16-week data from gene editing trial
BioCentury
Wed, 09/5/18 - 06:39 pm
Sangamo Therapeutics
Hunter Syndrome
SB-913
Highly anticipated trial results expected soon could move all three of these biotechs
Motley Fool
Mon, 09/3/18 - 12:07 pm
Sangamo Therapeutics
Esperion Therapeutics
Loxo Oncology
SB-913
bempedoic acid
LOXO-292
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Mon, 08/13/18 - 11:26 am
TG Therapeutics
Sangamo Therapeutics
Akcea Therapeutics
FDA
Waylivra
umbralisib
SB-913

Pages